Century Therapeutics, Inc.
Century Therapeutics, Inc. (IPSC): 6 pipeline candidates · ~16 mo cash runway · 3 clinical trials. Updated within the last hour.
BioSniper Score
5-factor signal · derived from public data
15.9 months
D/E 0.23 · 7% dilution
Lead: Phase 1
6 candidates
N/A
1 buy · 8 sells (180d)
A transparent, data-derived signal for Century Therapeutics, Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$404.9M
Cash
$53.8M
Quarterly Burn
$25.3M
Runway
15.9 mo
Revenue
—
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (6 candidates)
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
69
Total value held
$228.7M
| Holder | Shares | Value |
|---|---|---|
| ra capital management, l.p. | 17,754,430 | $40.1M |
| vanguard capital management llc | 11,372,408 | $25.7M |
| deep track capital, lp | 9,487,745 | $21.4M |
| commodore capital lp | 8,695,652 | $19.7M |
| rtw investments, lp | 8,695,652 | $19.7M |
| woodline partners lp | 6,086,956 | $13.8M |
| balyasny asset management l.p. | 5,017,733 | $11.3M |
| millennium management llc | 4,667,063 | $10.5M |
| spruce street capital lp | 4,059,054 | $9.2M |
| adage capital partners gp, l.l.c. | 3,789,538 | $8.6M |
Showing top 10 of 69 institutional holders of Century Therapeutics, Inc.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in Century Therapeutics, Inc.'s pipeline?
Century Therapeutics, Inc. (IPSC) has 6 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is Century Therapeutics, Inc.'s lead drug candidate?
Century Therapeutics, Inc.'s most advanced tracked candidate is cnty-101 (Phase 1) for Systemic Lupus Erythematosus; R/R CD19-Positive B-Cell Malignancies.
What is Century Therapeutics, Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, Century Therapeutics, Inc. has approximately 15.9 months of cash runway.
What is Century Therapeutics, Inc.'s market capitalization?
Century Therapeutics, Inc.'s market capitalization is approximately $404.9M.
Who is the CEO of Century Therapeutics, Inc.?
Dr. Brent Pfeiffenberger M.B.A., Pharm.D. is the chief executive officer of Century Therapeutics, Inc. (IPSC).
Get the full picture on Century Therapeutics, Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.